valerates has been researched along with thromboxane a2 in 3 studies
Studies (valerates) | Trials (valerates) | Recent Studies (post-2010) (valerates) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
---|---|---|---|---|---|
2,251 | 294 | 457 | 5,617 | 224 | 429 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banić, A; Kouris, K; Nazal, M; Rajacić, N; Thulesius, O | 1 |
Beetens, J; de Chaffoy de Courcelles, D; De Clerck, F; Freyne, E; Janssen, PA; Vercammen, E | 1 |
Aoki, N; Johnson, G; Lefer, AM; Siegfried, MR | 1 |
3 other study(ies) available for valerates and thromboxane a2
Article | Year |
---|---|
Increased skin flap viability after treatment with forskolin or with ridogrel, a thromboxane synthesis inhibitor and receptor blocker.
Topics: Animals; Colforsin; Graft Survival; Male; Microcirculation; Pentanoic Acids; Pyridines; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Skin; Surgical Flaps; Thromboxane A2; Valerates | 1990 |
R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Humans; In Vitro Techniques; Pentanoic Acids; Platelet Aggregation; Prostaglandin Endoperoxides; Pyridines; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase; Valerates | 1989 |
Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
Topics: Animals; Cathepsin D; Male; Myocardial Depressant Factor; Pentanoic Acids; Pyridines; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Shock, Traumatic; Thromboxane A2; Thromboxane-A Synthase; Valerates | 1989 |